首页> 外文期刊>Circulation journal >Attenuation of Diastolic Heart Failure and Life-ThreateningVentricular Tachyarrhythmia After Peripheral BloodStem Cell Transplantation Combined WithCardioverter-Defibrillator Implantation in Myeloma-Associated Cardiac Amyloidosis
【24h】

Attenuation of Diastolic Heart Failure and Life-ThreateningVentricular Tachyarrhythmia After Peripheral BloodStem Cell Transplantation Combined WithCardioverter-Defibrillator Implantation in Myeloma-Associated Cardiac Amyloidosis

机译:骨髓瘤相关性心肌淀粉样变性患者外周血干细胞移植联合心脏复律除颤器植入后舒张性心力衰竭和危及生命的室性心律失常

获取原文
获取原文并翻译 | 示例
           

摘要

A patient had multiple myeloma and associated cardiac amyloidosis, which caused diastolic dysfunction and recurrent ventricular fibrillation. After implantation of a cardioverter-defibrillator (ICD), the patient underwent autologous peripheral blood stem cell transplantation (PBSCT). The life-threatening arrhythmias, such as ventricular fibrillation, disappeared, and diastolic dysfunction assessed by quantitative gated single photon emission computed tomography and Doppler echocardiography improved 7 months later. This may be the first report to document improvement of both a lethal rhythm disorder and diastolic dysfunction by PBSCT following ICD implantation in a case of cardiac amyloidosis associated with multiple myeloma.
机译:一名患者患有多发性骨髓瘤并伴有心脏淀粉样变性,导致舒张功能障碍和反复的心室纤颤。植入心脏复律除颤器(ICD)后,患者接受了自体外周血干细胞移植(PBSCT)。通过定量门控单光子发射计算机断层扫描和多普勒超声心动图评估的危及生命的心律不齐,例如心室纤颤消失,舒张功能障碍改善,在7个月后有所改善。这可能是第一个报告,在与多发性骨髓瘤相关的心脏淀粉样变性患者中,植入ICD后,PBSCT可以改善致死性节律障碍和舒张功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号